Cargando…
Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma
BACKGROUND: The role of the PRDM5 in esophageal squamous cell carcinoma (ESCC) has not been revealed. This study investigated the relationship between PRDM5 expression and survival outcome in esophageal squamous cell carcinoma and explored the mechanism in tumor development. METHODS: In present stud...
Autores principales: | Guo, Jing, Yang, Qiuxing, Wei, Sheng, Shao, Jingjing, Zhao, Tianye, Guo, Liyuan, Liu, Jia, Chen, Jia, Wang, Gaoren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264607/ https://www.ncbi.nlm.nih.gov/pubmed/35799142 http://dx.doi.org/10.1186/s12885-022-09787-8 |
Ejemplares similares
-
Glycolytic Genes Predict Immune Status and Prognosis Non-Small-Cell Lung Cancer Patients with Radiotherapy and Chemotherapy
por: Zhao, Tianye, et al.
Publicado: (2023) -
DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis
por: Ji, Yan-Mei, et al.
Publicado: (2016) -
EHD2 inhibits the invasive ability of lung adenocarcinoma and improves the prognosis of patients
por: Wei, Sheng, et al.
Publicado: (2022) -
Hypertension predicts a poor prognosis in patients with esophageal squamous cell carcinoma
por: Liang, Jie, et al.
Publicado: (2018) -
Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma
por: Guo, Yan-li, et al.
Publicado: (2017)